Deimedis LT - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 289,164 | 254,825 | 136,216 | 423,025 | 146,166 | 67,981 | 150,738 | 248,651 |
| Profit before tax | 21,346 | 5,937 | 14,139 | 44,337 | -1,826 | -15,961 | 11,930 | 28,833 |
| Net profit | 20,274 | 5,640 | 13,421 | 37,668 | -2,302 | -15,961 | 11,333 | 27,061 |
| Equity | 87,748 | 93,388 | 106,809 | 144,477 | 142,175 | 126,214 | 129,047 | 131,108 |
| Liabilities | 37,047 | 16,937 | 21,923 | 49,474 | 67,008 | 1,639 | 13,353 | 39,675 |
| Non-current assets | 56,857 | 66,852 | 54,708 | 59,163 | 85,090 | 56,329 | 55,951 | 77,588 |
| Current assets | 67,938 | 43,473 | 74,024 | 134,788 | 124,093 | 71,524 | 86,449 | 93,195 |
| Total assets | 124,795 | 110,325 | 128,732 | 193,951 | 209,183 | 127,853 | 142,400 | 170,783 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 23,683 | 29,731 | 59,830 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -22.0% | -11.9% | -46.5% | +210.6% | -65.4% | -53.5% | +121.7% | +65.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 16.2% | 5.1% | 10.4% | 19.4% | -1.1% | -12.5% | 8.0% | 15.8% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 23.1% | 6.0% | 12.6% | 26.1% | -1.6% | -12.6% | 8.8% | 20.6% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 7.0% | 2.2% | 9.9% | 8.9% | -1.6% | -23.5% | 7.5% | 10.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 7.4% | 2.3% | 10.4% | 10.5% | -1.2% | -23.5% | 7.9% | 11.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.4 | 0.2 | 0.2 | 0.3 | 0.5 | 0.0 | 0.1 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 96,388 | 84,942 | 51,080 | 203,055 | 73,083 | 33,991 | 75,369 | 124,326 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Deimedis LT - Social security debts
The company had no debts to Sodra
Deimedis LT - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-22 | 2025-06-22 | 61.39 |
| 2025-06-17 | 2025-06-21 | 1.39 |
| 2025-06-15 | 2025-06-16 | 149.43 |
| 2025-03-22 | 2025-03-24 | 0.25 |
| 2025-03-20 | 2025-03-21 | 0.28 |
| 2025-03-19 | 2025-03-19 | 2942.58 |
| 2025-03-02 | 2025-03-18 | 1.01 |
| 2024-12-30 | 2025-01-15 | 0.2 |
| 2024-12-27 | 2024-12-28 | 0.2 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Deimedis LT, UAB (code 302915925) is a Private Limited Liability Company engaged in logging. In 2025, the company generated EUR 248.7K in revenue, up 65.0% year on year and 265.8% compared with 2023. Net profit increased to EUR 27.1K, after a loss of EUR 16.0K in 2023 and profit of EUR 11.3K in 2024, showing a clear improvement in profitability over the three-year period. The 2025 profit margin was 10.9%, supported by stronger sales growth and better operating performance. Balance sheet strength remained solid, with total assets of EUR 170.8K, equity of EUR 131.1K and liabilities of EUR 39.7K. The equity ratio stood at 76.8% and debt-to-equity at 0.30, indicating moderate leverage. Return on equity was 20.6% and return on assets 15.8%, while asset turnover reached 1.46x. Revenue per employee was EUR 124.3K and profit per employee EUR 13.5K, pointing to productive use of staff resources in 2025.